Cardiology And Nuclear Medicine Ltd Phoenix, AZ - 85006

Cardiology And Nuclear Medicine Ltd is categorized under Cardiologists in Phoenix, AZ and active since 1995.

Cardiology And Nuclear Medicine Ltd was established in 1995, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Cardiologists business, which does work in the B2C market, and is classified as a Cardiologists, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact M K Jasser at the company’s single location by writing to 1301 East Mcdowell Road # 202, Phoenix, Arizona AZ 85006 or by phoning (602) 251-3122. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cardiology And Nuclear Medicine Ltd
Contact Person: M K Jasser
Address: 1301 East Mcdowell Road # 202, Phoenix, Arizona 85006
Phone Number: (602) 251-3122
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1995
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Cardiologists
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Cardiology And Nuclear Medicine Ltd was started in 1995 to provide professional Cardiologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact M K Jasser for inquiries that concern Cardiology And Nuclear Medicine Ltd by calling the company number (602) 251-3122, as your correspondence is most welcome. Additionally, the physical location of the single location of Cardiology And Nuclear Medicine Ltd can be found at the coordinates 33.465594,-112.054085 as well as the street address 1301 East Mcdowell Road # 202 in Phoenix, Arizona 85006.

For its online presence, you may visit Cardiology And Nuclear Medicine Ltd’s website at and engage with its social media outlets through on Twitter and on Facebook.